Cargando…
Beneficial Effects of 6-Month Supplementation with Omega-3 Acids on Selected Inflammatory Markers in Patients with Chronic Kidney Disease Stages 1–3
INTRODUCTION: Chronic kidney disease (CKD) is accompanied by inflammation. The aim of this study was to evaluate the effect of 6-month supplementation with omega-3 acids on selected markers of inflammation in patients with CKD stages 1–3. METHODS: Six-month supplementation with omega-3 acids (2 g/da...
Autores principales: | Pluta, Agnieszka, Stróżecki, Paweł, Kęsy, Jacek, Lis, Kinga, Sulikowska, Beata, Odrowąż-Sypniewska, Grażyna, Manitius, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734005/ https://www.ncbi.nlm.nih.gov/pubmed/29349065 http://dx.doi.org/10.1155/2017/1680985 |
Ejemplares similares
-
Does Sevelamer Hydrochloride (Renagel) Influence 25(Oh)D3 and 1,25(Oh)2D3 Level in Haemodialysis Patients?
por: Strózecki, Pawel, et al.
Publicado: (2005) -
Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients
por: Donderski, Rafał, et al.
Publicado: (2017) -
Acceptance of Illness and Compliance with Therapeutic Recommendations in Patients with Hypertension
por: Pluta, Agnieszka, et al.
Publicado: (2020) -
Lipid Peroxidation, Advanced Glycation end Products and Antioxidant Status in Patients on Dialysis
por: Stefanska, Anna, et al.
Publicado: (2005) -
The fructose tolerance test in patients with chronic kidney disease and metabolic syndrome in comparison to healthy controls
por: Donderski, Rafał, et al.
Publicado: (2015)